Reversal of human cellular senescence: roles of the p53 and p16 pathways
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
Telomere erosion and subsequent dysfunction limits the proliferation of normal human cells by a process termed replicative senescence. Replicative senescence is thought to suppress tumorigenesis by establishing an essentially irreversible growth arrest that requires activities of the p53 and pRB tumor suppressor proteins. We show that, depending on expression of the pRB regulator p16, replicative senescence is not necessarily irreversible. We used lentiviruses to express specific viral and cellular proteins in senescent human fibroblasts and mammary epithelial cells. Expression of telomerase did not reverse the senescence arrest. However, cells with low levels of p16 at senescence resumed robust growth upon p53 inactivation, and limited growth upon expression of oncogenic RAS. In contrast, cells with high levels of p16 at senescence failed to proliferate upon p53 inactivation or RAS expression, although they re-entered the cell cycle without growth after pRB inactivation. Our results indicate that the senescence response to telomere dysfunction is reversible and is maintained primarily by p53. However, p16 provides a dominant second barrier to the unlimited growth of human cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“p16, an inhibitor of CDK4 and CDK6, is also key in several types of senescence26; p21 is activated early on senescence entry and p16 is activated later, probably to maintain the senescence phenotype27”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, cells that express low p16 INK4a levels (e.g., SEN(REP) or SEN(XRA) HCA2) senesce in response to severe damage by activating the p53 pathway; when p53 is subsequently inactivated in these cells, they resume proliferation [ 62 ], but do not lose the SASP.”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This accumulation results in persistent activation of RB family proteins, inhibition of E2F transactivation, and consequent cell-cycle arrest, which, in time, cannot be reversed by subsequent inactivation of RB family proteins or p53 (Beause ´ jour et al., 2003).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Beausejour et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In senescent cells, however, the CDK2 inhibitor p21 WAF1/Cip1 ( CDKN1A ) and CDK4/6 inhibitor p16 INK4A ( CDKN2A ) accumulate.”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Beausejour et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cell cycle controlling proteins p16, p21, and p53, normally inhibit cell cycle progression and have been shown to be accumulated in senescent cells [49–51].”
From T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment (2013) · cites this paper as [51]
Experimental — accuracy not yet measured
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Self-citationExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Self-citationSwitching and Signaling at the Telomere
Blackburn, E. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00492-5 · Cited by 2,107
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells
Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J., & Conklin, D. S. (2002) · Genes & Development · doi:10.1101/gad.981002 · Cited by 1,552
Cited by
Items 701–800 of 1,003
Aging Mechanisms: Linking oxidative stress, obesity and inflammation
Abbas, G., Salman, A., Rahman, S. U., Ateeq, M. K., Usman, M., Sajid, S., Zaheer, Z., & Younas, T. (2017) · Matrix Science Medica · doi:10.26480/msm.01.2017.30.33 · Cited by 29
Xu, X., Tsang, S. W., Guan, Y.-F., Liu, K., Pan, W.-H., Lam, C. S., Lee, K. M., Xia, Y.-X., Xie, W.-J., Wong, W., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01742 · Cited by 27
Yangonin inhibits ethanol-induced hepatocyte senescence via miR-194/FXR axis
Dong, R., Wang, X., Wang, L., Wang, C., Huang, K., Fu, T., Liu, K., Wu, J., Sun, H., & Meng, Q. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173653 · Cited by 30
Timmerman, D. M., Remmers, T. L., Hillenius, S., & Looijenga, L. H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105377 · Cited by 28
The Interplay Between Autophagy and Senescence in Anthracycline Cardiotoxicity
Russo, M., Bono, E., & Ghigo, A. (2021) · Current Heart Failure Reports · doi:10.1007/s11897-021-00519-w · Cited by 28
From the divergence of senescent cell fates to mechanisms and selectivity of senolytic drugs
L’Hôte, V., Mann, C., & Thuret, J. (2022) · Open Biology · doi:10.1098/rsob.220171 · Cited by 31
Wu, T., & Orschell, C. M. (2023) · International Journal of Radiation Biology · doi:10.1080/09553002.2023.2187479 · Cited by 33
The Effect of Cell–Matrix Interactions and Aging on the Malignant Process
Labat‐Robert, J., & Robert, L. (2007) · Advances in cancer research · doi:10.1016/s0065-230x(06)98007-5 · Cited by 30
Lysyl oxidase activity regulates oncogenic stress response and tumorigenesis
Wiel, C., Augert, A., Vincent, D. F., Gitenay, D., Vindrieux, D., Calvé, B. L., Arfi, V., Lallet-Daher, H., Reynaud, C., Treilleux, I., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.382 · Cited by 30
Photoprotection in Human Skin—A Multifaceted SOS Response†
Eller, M. S., Asarch, A., & Gilchrest, B. A. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00264.x · Cited by 30
Quake, S. R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.03.626516 · Cited by 57
The dual role of cellular senescence in human tumor progression and therapy
Ma, L., Yu, J., Fu, Y., He, X., Ge, S., Jia, R., Zhuang, A., Yang, Z. H., & Fan, X. (2024) · MedComm · doi:10.1002/mco2.695 · Cited by 33
Repopulation of Ovarian Cancer Cells after Chemotherapy
Telleria, C. M. (2013) · Cancer Growth and Metastasis · doi:10.4137/cgm.s11333 · Cited by 29
Ribero, S., Glass, D., Aviv, A., Spector, T. D., & Bataille, V. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116863 · Cited by 26
Bacqueville, D., Maret, A., Noizet, M., Duprat, L., Coutanceau, C., Georgescu, V., Bessou‐Touya, S., & Duplan, H. (2020) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s235880 · Cited by 33
Chen, C., Chen, J., Wang, W., Xie, L., Shao, C.-Q., & Zhang, Y. (2020) · Orthopaedic Surgery · doi:10.1111/os.12886 · Cited by 26
Vanegas, N.-D. P., Ruiz-Aparicio, P. F., Uribe, G. I., Ballesteros, A. L., & Vernot, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158166 · Cited by 28
Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner
Etxebeste-Mitxeltorena, M., del Rincón-Loza, I., & Martín-Antonio, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.717850 · Cited by 28
The chemotherapeutic agent doxorubicin induces brain senescence, with modulation by APOE genotype
Demby, T. C., Gross, P. S., Mandelblatt, J. S., Huang, J. K., & Rebeck, G. W. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114609 · Cited by 28
Cellular senescence, telomere recombination and maintenance
Yang, Q. (2008) · Cytogenetic and Genome Research · doi:10.1159/000167806 · Cited by 33
Lafferty-Whyte, K., Bilsland, A., Cairney, C. J., Hanley, L., Jamieson, N. B., Zaffaroni, N., Oien, K. A., Burns, S., Roffey, J., Boyd, S. M., et al. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-532 · Cited by 26
Pacheco-Rivera, R., Fattel‐Fazenda, S., Arellanes‐Robledo, J., Silva-Olivares, A., Alemán‐Lazarini, L., Rodríguez‐Segura, M. A., Pérez‐Carreón, J. I., Villa‐Treviño, S., Shibayama, M., & Serrano‐Luna, J. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.11.011 · Cited by 27
Fra‐1 plays a critical role in angiotensin II—induced vascular senescence
Yang, D., Xiao, C., Long, F., Wu, W., Huang, M., Qu, L., Liu, X., & Zhu, Y. Z. (2019) · The FASEB Journal · doi:10.1096/fj.201801671rrrr · Cited by 28
Glucocorticoids delay RAF-induced senescence promoted by EGR1
Carvalho, C., L’Hôte, V., Courbeyrette, R., Kratassiouk, G., Pinna, G., Cintrat, J., Wilkes, C. D., Derbois, C., Olaso, R., Deleuze, J., et al. (2019) · Journal of Cell Science · doi:10.1242/jcs.230748 · Cited by 29
Regulation of cellular senescence by Rb2/p130
Helmbold, H., Deppert, W., & Bohn, W. (2006) · Oncogene · doi:10.1038/sj.onc.1209613 · Cited by 33
A Critical Appraisal of the Utility of Targeting Therapy-Induced Senescence for Cancer Treatment
Saleh, T., Greenberg, E. F., Faber, A. C., Harada, H., & Gewirtz, D. A. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-2219 · Cited by 32
Ninomiya, Y., Cui, X., Yasuda, T., Wang, B., Yu, D. H., Sekine‐Suzuki, E., & Nenoi, M. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.10.254 · Cited by 27
Landry, Y., Lê, O., Mace, K. A., Restivo, T. E., & Beausejour, C. M. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00887.x · Cited by 30
Sun, L., Dou, F., Chen, J., Chi, H., Xing, S., Liu, T., Sun, S., & Chen, C. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7872 · Cited by 25
Bagge, J., MacLeod, J. N., & Berg, L. C. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.602403 · Cited by 28
Senescence: A program in the road to cell elimination and cancer
Moiseeva, O., Guillon, J., & Ferbeyre, G. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.017 · Cited by 25
Senescent Cells in Cancer: Wanted or Unwanted Citizens
Niklander, S. E., Lambert, D., & Hunter, K. D. (2021) · Cells · doi:10.3390/cells10123315 · Cited by 28
Mesenchymal Stem Cell Behavior under Microgravity: From Stress Response to a Premature Senescence
Pala, R., Cruciani, S., Manca, A., Garroni, G., Faqir, M. A. E., Lentini, V., Capobianco, G., Pantaleo, A., & Maioli, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097753 · Cited by 29
The specific role of pRb in p16INK4A-mediated arrest of normal and malignant human breast cells
Bazarov, A. V., Lee, W. J., Bazarov, I., Bosire, M., Hines, W. C., Stankovich, B., Chicas, A., Lowe, S. W., & Yaswen, P. (2012) · Cell Cycle · doi:10.4161/cc.11.5.19492 · Cited by 33
Self-citationNovel ARF/p53-independent senescence pathways in cancer repression
Chan, C., Gao, Y., Moten, A., & Lin, H. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0766-y · Cited by 29
Panda, S., Isbatan, A., & Adami, G. R. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.02.014 · Cited by 31
p16INK4a‐mediated suppression of telomerase in normal and malignant human breast cells
Bazarov, A. V., van Sluis, M., Hines, W. C., Bassett, E., Beliveau, A., Campeau, E., Mukhopadhyay, R., Lee, W. J., Melodyev, S., Zaslavsky, Y., et al. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00599.x · Cited by 28
Self-citationExploiting pivotal mechanisms behind the senescence-like cell cycle arrest in cancer
Zarneshan, S. N., Fakhri, S., Bachtel, G., & Bishayee, A. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.11.007 · Cited by 27
Age-Related Dysfunctions: Evidence and Relationship with Some Risk Factors and Protective Drugs
Libertini, G., Corbi, G., Cellurale, M. T., & Ferrara, N. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919120034 · Cited by 27
Non‐canonical ATM/MRN activities temporally define the senescence secretory program
Malaquin, N., Carrier-Leclerc, A., Martinez, A., Dessureault, M., Ghadaouia, S., Coppé, J., Nadeau, S., Cardin, G., Campisi, J., & Rodier, F. (2020) · EMBO Reports · doi:10.15252/embr.202050718 · Cited by 29
Self-citationSenotherapeutics in Cancer and HIV
Sánchez-Díaz, L., Espinosa-Sánchez, A., Blanco, J. R., & Carnero, A. (2022) · Cells · doi:10.3390/cells11071222 · Cited by 29
Braumüller, H., Mauerer, B., Berlin, C., Plundrich, D., Marbach, P., Cauchy, P., Laessle, C., Biesel, E. A., Holzner, P. A., & Kesselring, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.908449 · Cited by 26
Senescence: An Identity Crisis Originating from Deep Within the Nucleus
Olan, I., & Narita, M. (2022) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-120420-013537 · Cited by 25
Self-citationMaya‐Mendoza, A., Merchut‐Maya, J. M., Bártková, J., Bártek, J., Streuli, C. H., & Jackson, D. A. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.315 · Cited by 25
Emerging role of polymerase-1 and transcript release factor (PTRF/ Cavin-1) in health and disease
Low, J., & Nicholson, H. D. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1964-z · Cited by 27
The impact of cellular senescence in cancer therapy: is it true or not?
Zhang, Y., & Yang, J. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.108 · Cited by 32
Senescence of Nucleus Pulposus Chondrocytes in Human Intervertebral Discs
Kim, K.-W., Ha, K.-Y., Lee, J.-S., Na, K.-H., Kim, Y., & Woo, Y.-K. (2008) · Asian Spine Journal · doi:10.4184/asj.2008.2.1.1 · Cited by 25
Oh, S., Park, S., Lee, K.-W., Madhi, H., Park, S. G., Lee, H. G., Cho, Y., Yoo, J., & Kim, K. D. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.153 · Cited by 27
Gire, V. (2005) · médecine/sciences · doi:10.1051/medsci/2005215491 · Cited by 41
Wang, Y., Xu, Q., Sack, L. M., Kang, C., & Elledge, S. J. (2016) · Genes & Development · doi:10.1101/gad.271445.115 · Cited by 24
Dhokia, V., Albati, A., Smith, H., Thomas, G., & Macip, S. (2024) · Biochemical Society Transactions · doi:10.1042/bst20231066 · Cited by 26
Raghavan, A., Kashyap, R., Sreedevi, P. R., Jos, S., Chatterjee, S., Alex, A., D’Souza, M. N., Giridharan, M., Muddashetty, R. S., Manjithaya, R. R., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110565 · Cited by 23
Autophagy-independent senescence and genome instability driven by targeted telomere dysfunction
Mar, F. A., Debnath, J., & Stohr, B. A. (2015) · Autophagy · doi:10.1080/15548627.2015.1017189 · Cited by 25
Recent progress in genetics of aging, senescence and longevity: focusing on cancer-related genes
Berman, A. E., Leontieva, O. V., Natarajan, V., McCubrey, J. A., Demidenko, Z. N., & Nikiforov, M. A. (2012) · Oncotarget · doi:10.18632/oncotarget.889 · Cited by 29
Induction, regulation and roles of neural adhesion molecule L1CAM in cellular senescence
Mrázková, B., Dzijak, R., Hornofova, T., Kyjacová, L., Baráth, P., Džubák, P., Holub, D., Hajdúch, M., Nahácka, Z., Anděra, L., et al. (2018) · Aging · doi:10.18632/aging.101404 · Cited by 29
Mesenchymal Stem Cell Senescence and Osteogenesis
Tjempakasari, A., Suroto, H., & Santoso, D. (2021) · Medicina · doi:10.3390/medicina58010061 · Cited by 29
Moquin‐Beaudry, G., Benabdallah, B., Maggiorani, D., Lê, O., Li, Y., Colas, C., Raggi, C. C., Ellezam, B., M’Callum, M.-A., Soglio, D. B. D., et al. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2021.100153 · Cited by 24
Exploiting cellular senescence to treat cancer and circumvent drug resistance
Yan, Q., & Wajapeyee, N. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.3.11166 · Cited by 24
Borodkina, A. V., Shatrova, A. N., Deryabin, P. I., Grukova, A. A., Nikolsky, N. N., & Burova, E. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1121326 · Cited by 24
Shining the Light on Senescence Associated LncRNAs
Ghanam, A. R., Xu, Q., Ke, S., Azhar, M., Cheng, Q., & Song, X. (2017) · Aging and Disease · doi:10.14336/ad.2016.0810 · Cited by 26
Neault, M., Couteau, F., Bonneau, É., Guire, V. D., & Mallette, F. A. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.04.001 · Cited by 23
Yang, L., Xing, S., Wang, K., Hua, Y., & Du, B. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3141-7 · Cited by 25
Role of melanoma inhibitory activity in melanocyte senescence
Feuerer, L., Lamm, S., Henz, I., Kappelmann‐Fenzl, M., Haferkamp, S., Meierjohann, S., Hellerbrand, C., Kuphal, S., & Bosserhoff, A. (2019) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12801 · Cited by 41
Peng, X., Zhang, C., Bao, J.-P., Zhu, L., Shi, R. H., Xie, Z., Wang, F., Wang, K., & Wu, X. (2020) · Bone and Joint Research · doi:10.1302/2046-3758.95.bjr-2019-0230.r1 · Cited by 23
Empagliflozin rescues lifespan and liver senescence in naturally aged mice
Long, J., Ren, Z., Duan, Y., Tao, W., Li, X., Li, S., Li, K., Huang, Q., Chen, J., Yang, M., et al. (2024) · GeroScience · doi:10.1007/s11357-024-01250-9 · Cited by 25
Pfeuty, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035291 · Cited by 25
Zhao, Z., Fowle, H. A., Valentine, H., Liu, Z., Tan, Y., Pei, J., Badal, S. A. M., Testa, J. R., & Graña, X. (2020) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-020-00274-4 · Cited by 29
Russo, M., Spagnuolo, C., Moccia, S., Tedesco, I., Lauria, F., & Russo, G. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010301 · Cited by 21
Protective effects of ginsenoside Rg1 on aging Sca-1+ hematopoietic cells
Zhou, Y., Liu, J., Cai, S., Liu, D., Jiang, R., & Wang, Y. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3884 · Cited by 22
Harajly, M., Zalzali, H., Nawaz, Z., Ghayad, S. E., Ghamloush, F., Basma, H., Zainedin, S., Rabeh, W., Jabbour, M. N., Tawil, A. N., et al. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00747-15 · Cited by 24
Xu, T., Chen, J., Zhu, D., Chen, L., Wang, J., Sun, X., Hu, B., & Duan, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-00326-1 · Cited by 21
Endothelial Cell Senescence in the Pathogenesis of Endothelial Dysfunction
Carracedo, J., Ramírez-Carracedo, R., Alique, M., & Ramírez, R. (2018) · InTech eBooks · doi:10.5772/intechopen.73024 · Cited by 31
Reversible Growth-Arrest of a Spontaneously-Derived Human MSC-Like Cell Line
Melzer, C., Jacobs, R., Dittmar, T., Pich, A., von der Ohe, J., Yang, Y., & Hass, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134752 · Cited by 22
Batsi, C., Markopoulou, S., Vartholomatos, G., Georgiou, I., Kanavaros, P., Gorgoulis, V. G., Marcu, K. B., & Kolettas, E. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.04.002 · Cited by 22
Targeting vascular senescence in cardiovascular disease with aging
Hall, S. A., & Lesniewski, L. A. (2024) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.45 · Cited by 32
Šímová, J., Sapega, O., Hornofova, T., Štěpánek, I., Kyjacová, L., Mikyšková, R., Indrová, M., Bieblová, J., Bubenik, J., Bártek, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10712 · Cited by 27
Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma
Krayem, M., Najem, A., Journé, F., Morandini, R., Salès, F., Awada, A. H., & Ghanem, G. (2018) · Oncotarget · doi:10.18632/oncotarget.25879 · Cited by 24
RetractedNuclear localization of p65 reverses therapy-induced senescence
Salunkhe, S. J., Mishra, S. V., Nair, J., Shah, S. G., Gardi, N., Thorat, R. A., Sarkar, D., Rajendra, J., Kaur, E., & Dutt, S. (2021) · Journal of Cell Science · doi:10.1242/jcs.253203 · Cited by 21
Kim, H. J., Kim, B., Byun, H. J., Yu, L., Nguyen, T. M., Nguyen, T. H., Do, P. A., Kim, E. J., Cheong, K. A., Kim, K. S., et al. (2021) · Antioxidants · doi:10.3390/antiox10121924 · Cited by 28
Eymael, J., Willemsen, B. K., Xu, J. Y., Mooren, F., Steenbergen, E., Wetzels, J. F. M., Dijkman, H. B. P. M., Jansen, J., van der Vlag, J., & Smeets, B. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.765887 · Cited by 21
Saleh, T., Khasawneh, A. I., Himsawi, N. M., Abu-Raideh, J. A., Ejeilat, V., Elshazly, A. M., & Gewirtz, D. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415512 · Cited by 24
The roles of miRNAs in adult skeletal muscle satellite cells
Koopmans, P. J., Ismaeel, A., Goljanek‐Whysall, K., & Murach, K. A. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.10.403 · Cited by 23
Therapeutic strategies targeting cellular senescence for cancer and other diseases
Wang, X., Fukumoto, T., & Noma, K.-I. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae015 · Cited by 29
Balamurli, G., Liew, A. Q. X., Tee, W., & Pervaiz, S. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103441 · Cited by 25
Stem cell aging in the Drosophila ovary
Waskar, M., Li, Y., & Tower, J. (2005) · AGE · doi:10.1007/s11357-005-2914-1 · Cited by 21
Self-Renewal Signalling in Presenescent Tetraploid IMR90 Cells
Huna, A., Salmiņa, K., Jascenko, E., Duburs, G., Inashkina, I., & Erenpreisa, J. A. (2011) · Journal of Aging Research · doi:10.4061/2011/103253 · Cited by 24
Evidence of cellular senescence during the development of estrogen-induced pituitary tumors
Sabatino, M. E., Petiti, J. P., Sosa, L. D. V., Pérez, P. A., Gutiérrez, S., Leimgruber, C., Latini, A., Torres, A. I., & Paul, A. L. D. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0333 · Cited by 28
hTERT Extends the Life of Human Fibroblasts without Compromising Type I Interferon Signaling
Smith, M. C., Goddard, E. T., Lanfranca, M. P., & Davido, D. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058233 · Cited by 22
Cotarelo, C., Schad, A., Kirkpatrick, C. J., Sleeman, J. P., Springer, E., Schmidt, M., & Thaler, S. (2016) · Oncotarget · doi:10.18632/oncotarget.12432 · Cited by 23
Direct Conversion Through Trans-Differentiation: Efficacy and Safety
Prasad, A., Teh, D. B. L., Jahan, F. R. S., Manivannan, J., Chua, S. M., & All, A. H. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0174 · Cited by 21
Characterization of the EBV-Induced Persistent DNA Damage Response
Hafez, A. Y., & Luftig, M. A. (2017) · Viruses · doi:10.3390/v9120366 · Cited by 21
Establishment of an erythroid cell line from primary CD36+ erythroid progenitor cells
Wong, S. C., Keyvanfar, K., Wan, Z., Kajigaya, S., Young, N. S., & Zhi, N. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.07.012 · Cited by 22
Une re-vue de la sénescence cellulaire: Ami ou ennemi de la promotion tumorale ?
Bischof, O., Dejean, A., & Pineau, P. (2009) · médecine/sciences · doi:10.1051/medsci/2009252153 · Cited by 32
Distinct Mechanisms Control Human Naive and Antigen-Experienced CD8+ T Lymphocyte Proliferation
Migliaccio, M., Alves, P. M. S., Romero, P. J., & Rufer, N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2173 · Cited by 24
Chromatin Modification and Senescence: Linkage by Tumor Suppressors?
Han, X., Berardi, P., & Riabowol, K. T. (2006) · Rejuvenation Research · doi:10.1089/rej.2006.9.69 · Cited by 22
Therapy-induced senescence is finally escapable, what is next?
Saleh, T. (2024) · Cell Cycle · doi:10.1080/15384101.2024.2364579 · Cited by 24
Thompson, E. L., Hu, J., & Niedernhofer, L. J. (2021) · Cancers · doi:10.3390/cancers13092241 · Cited by 20
Tran, A. P., Tralie, C. J., Reyes, J. S., Moosmüller, C., Belkhatir, Z., Kevrekidis, I. G., Levine, A. J., Deasy, J. O., & Tannenbaum, A. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01069-x · Cited by 24
Caveolae and the oxidative stress response
Wu, Y., Lim, Y., & Parton, R. G. (2023) · Biochemical Society Transactions · doi:10.1042/bst20230121 · Cited by 20
Quantitative Analysis of Cellular Senescence in Culture and In Vivo
Zhao, J., Fuhrmann‐Stroissnigg, H., Gurkar, A. U., Flores, R. R., Dorronsoro, A., Stolz, D. B., Croix, C. M. S., Niedernhofer, L. J., & Robbins, P. D. (2017) · Current Protocols in Cytometry · doi:10.1002/cpcy.16 · Cited by 22
Metadata
- Authors
- Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- Salk Institute for Biological Studies (US)
- Cold Spring Harbor Laboratory (US)
- Buck Institute for Research on Aging (US)
- Corresponding author
- Campisi, Judith
- Venue
- The EMBO Journal
- Published
- 2003-08-15
- Volume
- 22
- Issue
- 16
- Pages
- 4212-4222
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC175806
- OpenAlex
- W2061619522
- Cited by
- 1,457
- References
- 61
- Citations by year
- 2026: 46 · 2025: 58 · 2024: 87 · 2023: 94 · 2022: 77 · 2021: 107 · 2020: 77 · 2019: 77 · 2018: 78 · 2017: 63 · 2016: 74 · 2015: 55 · 2014: 59 · 2013: 54 · 2012: 69
- FWCI
- 21.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- The EMBO Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Funders
- Uehara Memorial Foundation
- National Institute on Aging (R56AG009909, R56AG016379, AG-09909, AG-16379, R01AG016379, R37AG009909)
- National Cancer Institute (P30CA008748)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, replicative senescence, p53, p16, retinoblastoma protein, telomere dysfunction, telomerase, oncogenic Ras, growth arrest, senescence reversal, mammary epithelial cells, fibroblasts, tumor suppression
- MeSH terms
- Breast, Cell Line, Epithelial Cells, Fibroblasts, Humans, Luminescent Proteins, Models, Biological, Genes, ras, Signal Transduction, Tumor Suppressor Protein p53, Lentivirus Infections, Cellular Senescence, Telomerase, Cyclin-Dependent Kinase Inhibitor p16, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.